COMPARISON OF DIAGNOSTIC ACCURACY BETWEEN THE RISK OF MALIGNANCY INDEX (RMI) AND THE RISK OF OVARIAN MALIGNANCY ALGORITHM (ROMA) TO ASSUME ANY MALIGNANCY IN OVARIAN TUMOR.

Malignancy of the ovary has a high incidence, however there are still many cases of undiagnosed ovarian malignancy. Many cases diagnosed as benign ovarian tumors during surgery show the results turned out to be malignant. The prognosis of ovarian malignancy is highly dependent on the results of the first surgery to achieve as much as possible cytoreduction. Currently to diagnose ovarian malignancy the Risk of Malignancy Index (RMI) score is used among other methods, however diagnostic capability for early detection of ovarian malignancy is still not good enough. Risk of Ovarian Malignancy Algorithm (ROMA) is an alternative diagnostic test in the early detection of ovarian malignancy. This study aimed to compare the diagnostic test capability between RMI and ROMA in suspected malignant ovarian tumors. Subjects were all patients diagnosed with ovarian tumors and planned to undergo operation in the Hasan Sadikin Hospital. RMI and ROMA scores were calculated, then compared the results obtained with postoperative histopathology results. A statistical analysis of sensitivity and specificity calculations of both scores in detecting ovarian malignancy was performed. Obtained 17 subjects research studies that met the inclusion criteria. Of the 17 there were 10 cases of malignancy and 7 cases of benign. There was no significant difference (p>0.05) on the characteristics of the study subjects by age and menopausal status. The results of the study showed that regarding the diagnostic test scores ROMA had a sensitivity of 80% and a specificity 85.5%, while the RMI had sensitivity of 30% and specificity of 71.4%. In conclusion ROMA scores has better diagnostic test capability than RMI in suspected malignant ovarian tumors.